1-3 of 3
Kristof Vercruysse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models

Brief Report
Marc V. A. van Moorsel, Steven de Maat, Kristof Vercruysse, Esther M. van Leeuwen, Charlène Jacqmarcq, Thomas Bonnard, Denis Vivien, H. Bart van der Worp, Rick M. Dijkhuizen, Coen Maas
Journal: Blood
Blood (2022) 140 (26): 2844–2848.
https://doi.org/10.1182/blood.2022016342
Published: 2022
Includes: Supplemental data
Journal Articles

Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis

Steven de Maat, Chantal C. Clark, Arjan D. Barendrecht, Simone Smits, Nadine D. van Kleef, Hinde El Otmani, Manon Waning, Marc van Moorsel, Michael Szardenings, Nicolas Delaroque, Kristof Vercruysse, Rolf T. Urbanus, Silvie Sebastian, Peter J. Lenting, Christoph Hagemeyer, Thomas Renné, Karen Vanhoorelbeke, Claudia Tersteeg, Coen Maas
Journal: Blood
Blood (2022) 139 (4): 597–607.
https://doi.org/10.1182/blood.2021011776
Published: 2022
Includes: Supplemental data
Journal Articles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Khalid Abd-Elaziz, Pieter W. Kamphuisen, Christophe Lyssens, Mariska Reuvers, Izaak den Daas, Femke Van Bockstaele, Kristof Vercruysse, Hans Ulrichts, Judith Baumeister, Patricia Crabbe, Veerle Compernolle, Josefin-Beate Holz
Journal: Blood
Blood (2009) 114 (22): 1063.
https://doi.org/10.1182/blood.V114.22.1063.1063
Published: 2009